Half of those treated with the experimental immunotherapy bb2121 no longer had detectable cancer.

This is the first treatment advance in 30 years for rhabdomyosarcoma.

California study showed that women were less likely to get aggressive treatment and more likely to die of cancer.

World’s largest cancer conference covers all aspects of treatment, care and survivorship.

LOXO-292 demonstrates durable antitumor activity in people with lung, thyroid and other cancers.

Studies show African-American men may respond better to treatment and survive longer.

Cross-border collaboration compared findings in British Columbia and Washington state.

Cancer Health will be reporting live from Chicago, June 1-5.

Experts urge public health campaign to highlight the benefits of early detection.

Both approaches can offer non-pharmaceutical alternatives to sleep medications.